A study by researchers at Baylor College of Medicine and collaborating institutions reveals a previously unrecognized way ...
Interim clinical data from GFORCE-1 trial of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in subjects with elevated CVD risk; ...
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company ...
PM ET Event will feature Phase 1 clinical data for BGE-102 and the therapeutic rationale for development in atherosclerotic cardiovascular disease (ASCVD) and retinal disease Four leading academic and ...
Conference Call and Webcast Today, May 7, 2026, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal ...
Publication in Science magazine outlines blueprint for the scalable synthesis of complex orally available macrocyclic peptidesEnlicitide, a novel macrocyclic peptide, has the potential to be the first ...
The issue is hard to study. Stress cannot be objectively measured like blood pressure. Still, keeping your cool does matter.
High cholesterol tends to fly under the radar, often building quietly without obvious symptoms. Over time, elevated levels ...
Scientists report that a new DNA-based treatment lowered bad cholesterol by nearly 50% after one injection targeting the ...
"Regular bloodwork is important if you have a known cardiovascular problem or if you are taking cholesterol medication," ...
Decisions on regulatory approval from EMA, UK, and Switzerland for obicetrapib and obicetrapib/ezetimibe fixed-dose combination expected in 2H26, and based on the outcomes, with potential launches by ...
Experts have warned Britain is likely to be one of the countries hardest hit by jet fuel shortages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results